81 related articles for article (PubMed ID: 8275036)
41. Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
Topolsky D; Crilley P; Styler MJ; Bulova S; Brodsky I; Marks DI
Bone Marrow Transplant; 1996 Apr; 17(4):549-54. PubMed ID: 8722353
[TBL] [Abstract][Full Text] [Related]
42. The effects of pentoxifylline on the prevention of cyclosporine-induced nephrotoxicity in cardiac transplant patients.
White JR; Rockwood T; Wilson D; Bettesworth L; Icenogle T
Clin Ther; 1994; 16(4):673-9. PubMed ID: 7982255
[TBL] [Abstract][Full Text] [Related]
43. Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial.
Attal M; Huguet F; Rubie H; Charlet JP; Schlaifer D; Huynh A; Laurent G; Pris J
Blood; 1993 Aug; 82(3):732-6. PubMed ID: 8338943
[TBL] [Abstract][Full Text] [Related]
44. The maximal tolerable intravenous dosage of pentoxifylline in AIDS patients does not inhibit lipopolysaccharide-stimulated tumor necrosis factor alpha production.
Heijligenberg R; Romijn JA; Ackermans M; Endert E; Timmer JG; Sauerwein HP
AIDS Res Hum Retroviruses; 1998 Mar; 14(4):299-303. PubMed ID: 9519890
[TBL] [Abstract][Full Text] [Related]
45. Effect of intravenous pentoxifylline in inflammatory response in patients undergoing nephrolithotomy.
Izadpanah F; Mojtahedzadeh M; Kazem Aghamir SM; Atharikia D; Dashti S; Abbasi A
J Endourol; 2009 Feb; 23(2):323-8. PubMed ID: 19220089
[TBL] [Abstract][Full Text] [Related]
46. Effects of pentoxifylline on liver regeneration: a double-blinded, randomized, controlled trial in 101 patients undergoing major liver resection.
Petrowsky H; Breitenstein S; Slankamenac K; Vetter D; Lehmann K; Heinrich S; DeOliveira ML; Jochum W; Weishaupt D; Frauenfelder T; Graf R; Clavien PA
Ann Surg; 2010 Nov; 252(5):813-22. PubMed ID: 21037437
[TBL] [Abstract][Full Text] [Related]
47. Adverse reactions related to i.v. infusion of high-dose cyclophosphamide in bone marrow transplant patients.
Schwinghammer TL; Wiggins LE; Burgunder MR; Michell TE; Bailey WL
Am J Hosp Pharm; 1994 Oct; 51(19):2419-21. PubMed ID: 7847409
[No Abstract] [Full Text] [Related]
48. Effects of oral pentoxifylline on TNF-alpha levels, transplant-related toxicities and engraftment after bone marrow transplantation.
Lopez-Jimenez J; Cancelas JA; Valiño JM; Garcia-Laraña J; Garcia-Avello A; Arranz MI; Perez-Oteyza J; Ramos P; Odriozola J
Bone Marrow Transplant; 1994 Dec; 14(6):1011-2. PubMed ID: 7794347
[No Abstract] [Full Text] [Related]
49. High dose busulfan and seizures.
De La Camara R; Tomas JF; Figuera A; Berberana M; Fernandez-Rañada JM
Bone Marrow Transplant; 1991 May; 7(5):363-4. PubMed ID: 2070145
[TBL] [Abstract][Full Text] [Related]
50. Prevention studies with pentoxifylline: new clinical projects.
Eugène-Jolchine I; Milpied N
J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S143-6. PubMed ID: 8699855
[TBL] [Abstract][Full Text] [Related]
51. Pentoxifylline did not prevent transplant-related toxicity in 31 consecutive allogeneic bone marrow transplant recipients.
Kalhs P; Lechner K; Stockschläder M; Krüger W; Peters S; Zander A
Blood; 1992 Nov; 80(10):2683-4. PubMed ID: 1421382
[No Abstract] [Full Text] [Related]
52. Pentoxifylline and ciprofloxacin in patients with myelodysplastic syndrome. A phase II trial.
Nemunaitis J; Rosenfeld C; Getty L; Boegel F; Meyer W; Jennings LW; Zeigler Z; Shadduck R
Am J Clin Oncol; 1995 Jun; 18(3):189-93. PubMed ID: 7747704
[TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetics of pentoxifylline and its main metabolites in patients with different degrees of heart failure following a single dose of a modified-release formulation.
Nisi A; Panfili M; De Rosa G; Boffa G; Groppa F; Gusella M; Padrini R
J Clin Pharmacol; 2013 Jan; 53(1):51-7. PubMed ID: 23400743
[TBL] [Abstract][Full Text] [Related]
54. Reversible central nervous system toxicity associated with high-dose chlorambucil in autologous bone marrow transplantation for ovarian carcinoma.
Ciobanu N; Runowicz C; Gucalp R; Frank M; Charuvanki V; Kaufman D; Wiernik PH
Cancer Treat Rep; 1987 Dec; 71(12):1324-5. PubMed ID: 3319137
[No Abstract] [Full Text] [Related]
55. High-dose 1,2,4-triglycidylurazol given in regimens preparatory to bone marrow transplantation. A preclinical pharmacology study.
Beelen DW; Schilcher RB; Ehrlich R; Quabeck K; Schmidt U; Szy D; Grosse-Wilde H; Becher R; Schaefer UW
Cancer Chemother Pharmacol; 1991; 27(5):361-6. PubMed ID: 1998996
[TBL] [Abstract][Full Text] [Related]
56. Effect of intravenous pentoxifylline on oxidative stress in patients undergoing nephrolithotomy.
Mojtahedzadeh M; Izadpanah F; Kazem Aghamir SM; Atharikia D; Reza Nikoobahkt M; Abbasi A
Minerva Urol Nefrol; 2008 Sep; 60(3):151-7. PubMed ID: 18787510
[TBL] [Abstract][Full Text] [Related]
57. Acute psychotic reaction to pentoxifylline.
Jain AP; Kazi RA; Diwan SK; Gupta OP; Jajoo UN
J Assoc Physicians India; 1992 Jul; 40(7):479. PubMed ID: 1484035
[No Abstract] [Full Text] [Related]
58. The effect of pentoxifylline on haemolysis in patients with double cardiac prosthetic valves.
Golbasi I; Turkay C; Timuragaoglu A; Ozdem SS; Belgi A; Akbas H; Bayezid O
Acta Cardiol; 2003 Oct; 58(5):379-83. PubMed ID: 14609301
[TBL] [Abstract][Full Text] [Related]
59. Evidence that oral pentoxifylline reverses acute renal dysfunction in bone marrow transplant recipients receiving amphotericin B and cyclosporine. Results of a pilot study.
Bianco JA; Almgren J; Kern DL; Ballard B; Roark K; Andrews F; Nemunaitis J; Shields T; Singer JW
Transplantation; 1991 Apr; 51(4):925-7. PubMed ID: 2014558
[No Abstract] [Full Text] [Related]
60. Prospective study of adverse drug reactions of antihypertensive drugs in Thai outpatients.
Makarananda K; Sriwatanakul K; Pothisiri P; Eamrungroj S; Charoonroj P; Pongprayoon U
J Med Assoc Thai; 1985 May; 68(5):229-36. PubMed ID: 4031716
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
